ALPS Medical Breakthroughs ETF
SBIO
NYSE Arca
| Weiss Ratings | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Reward Grade | D+ | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Valuation | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Price | $51.64 | |||
| Company Info | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | ALPS | |||
| Manager/Tenure (Years) | Ryan Mischker (11), Kyle Kleckner (0) | |||
| Website | http://www.alpsfunds.com | |||
| Phone Number | 866-759-5679 | |||
| Fund Information | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | ALPS Medical Breakthroughs ETF | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Dec 30, 2014 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.00% | |||
| Dividend | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.00% | |||
| Asset Allocation | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.01% | |||
| Stock | 99.98% | |||
| U.S. Stock | 91.40% | |||
| Non-U.S. Stock | 8.58% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -10.30% | |||
| 30-Day Total Return | -23.69% | |||
| 60-Day Total Return | -18.57% | |||
| 90-Day Total Return | -20.43% | |||
| Year to Date Total Return | 1.14% | |||
| 1-Year Total Return | 29.86% | |||
| 2-Year Total Return | 44.79% | |||
| 3-Year Total Return | 104.72% | |||
| 5-Year Total Return | 16.91% | |||
| Price | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | $56.15 | |||
| 1-Month Low Price | $56.15 | |||
| 1-Month High Price | $67.66 | |||
| 52-Week Low Price | $39.85 | |||
| 52-Week Low Price (Date) | Oct 03, 2025 | |||
| 52-Week High Price | $70.79 | |||
| 52-Week High Price (Date) | Aug 19, 2026 | |||
| NAV | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| 1-Month Low NAV | $56.22 | |||
| 1-Month High NAV | $67.58 | |||
| 52-Week Low NAV | $39.82 | |||
| 52-Week Low NAV (Date) | Oct 03, 2025 | |||
| 52-Week High NAV | $70.68 | |||
| 52-Week High Price (Date) | Aug 19, 2026 | |||
| Beta / Standard Deviation | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.93 | |||
| Standard Deviation | 28.42 | |||
| Balance Sheet | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 211.56M | |||
| Operating Ratios | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.50% | |||
| Turnover Ratio | 58.00% | |||
| Performance | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 73.97% | |||
| Last Bear Market Total Return | -17.81% | |||